Sustainability in industrial biotech innovations: life cycle assessment and beyond
Get ready for EFIB 2021 by attending the kick-off webinar “Sustainability in Industrial biotech innovations: Life Cycle Assessment and beyond”, which will take place on Tuesday 21 September 2021 from 14.30 – 15.30 CET.
Sustainability is the drive and purpose behind most industrial biotech innovations. But how to incorporate it in the innovation process? How to assess it, measure it, and use it for decision making? During this webinar we will explore:
• How well-established tools like Life Cycle Assessment are being used in industrial biotech innovations
• What are novel tools and methodologies relevant for the sustainability assessment of industrial biotech
• How corporates, start-ups and academia use these tools in their innovation process
This kick-off webinar by EuropaBio is co-hosted by Planet B.io, the open innovation hub for industrial biotechnology, located at the Biotech Campus Delft in The Netherlands.
Moderator:
• Maria Cuellar-Soares | S&T Officer, Planet B.io
Speakers:
• Ulla Létinois | Senior Scientist, Sustainable Chemistry, DSM
• Yang Xiang | Senior Corporate LCA Expert, DSM
• Cristina Prat | Co-founder, FUL Foods
• John Posada | Assistant Professor in Biotechnology and Society, TU Delft
Participation for this webinar is free of charge, but registration is required.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Algal Omage-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of algal omega-3 used.